Committee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: All time
Money over time
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 56.6% of total raised.
Dominant category: Operations at 88.8% of spending.
Donor count
671
Contributions
1,106
Median
$390
Average
$1,374
Funding distribution
$5,000+
Count: 105
Share: 56.6%
Amount: $859,925
$1,000 - $4,999
Count: 188
Share: 27.8%
Amount: $421,886
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageCommittee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: All time
Money over time
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 56.6% of total raised.
Dominant category: Operations at 88.8% of spending.
Donor count
671
Contributions
1,106
Median
$390
Average
$1,374
Funding distribution
$5,000+
Count: 105
Share: 56.6%
Amount: $859,925
$1,000 - $4,999
Count: 188
Share: 27.8%
Amount: $421,886
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageCount: 158
Share: 6.7%
Amount: $101,633
$100 - $499
Count: 589
Share: 8.9%
Amount: $134,826
$1 - $99
Count: 35
Share: 0.1%
Amount: $1,647
Spending categories
Operations
Amount: $1,233,382
Share: 88.8%
Consulting
Amount: $130,539
Share: 9.4%
Field
Amount: $18,275
Share: 1.3%
Media
Amount: $6,141
Share: 0.4%
Refunds and adjustments: 1 entries, -$165 total.
Count: 158
Share: 6.7%
Amount: $101,633
$100 - $499
Count: 589
Share: 8.9%
Amount: $134,826
$1 - $99
Count: 35
Share: 0.1%
Amount: $1,647
Spending categories
Operations
Amount: $1,233,382
Share: 88.8%
Consulting
Amount: $130,539
Share: 9.4%
Field
Amount: $18,275
Share: 1.3%
Media
Amount: $6,141
Share: 0.4%
Refunds and adjustments: 1 entries, -$165 total.
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| BIOCOM PURCHASING GROUP | $259,900 | 17.1% | 3 | Aug 13, 2022 |
| GENENTECH | $73,750 | 4.9% | 16 | Sep 30, 2013 |
| GENENTECH | $55,000 | 3.6% | 9 | Aug 20, 2019 |
| NEUROCRINE BIOSCIENCES, INC. | $53,155 | 3.5% | 7 | Dec 18, 2025 |
| NOVARTIS | $34,300 | 2.3% | 8 | Aug 29, 2024 |
| ARENA PHARMACEUTICALS | $33,815 | 2.2% | 9 | Mar 23, 2011 |
| LIFE TECHNOLOGIES | $27,100 | 1.8% | 7 | Dec 23, 2014 |
| PFIZER INC. | $26,800 | 1.8% | 6 | Oct 23, 2018 |
| GILEAD SCIENCES, INC. | $24,900 | 1.6% | 3 | Mar 12, 2025 |
| BIOGEN IDEC PHARMACEUTICALS CORP | $23,495 | 1.5% | 6 | Jul 26, 2010 |
| INVITROGEN | $21,650 | 1.4% | 5 | May 28, 2008 |
| SUNOVION PHARMACEUTICALS INC. | $21,500 | 1.4% | 6 | Nov 1, 2022 |
| AMGEN INC. | $20,000 | 1.3% | 4 | Oct 3, 2024 |
| AMGEN INC. STATE POLITICAL CONTRIBUTIONS ACCOUNT REVOCABLE TRUST | $20,000 | 1.3% | 4 | Oct 5, 2023 |
| LIGAND PHARMACEUTICALS | $20,000 | 1.3% | 6 | Oct 12, 2006 |
| SEMPRA ENERGY | $18,000 | 1.2% | 6 | Jul 2, 2019 |
| GEN-PROBE, INC. | $14,650 | 1% | 5 | Jul 28, 2010 |
| NOVARTIS PHARMACEUTICALS CORP. | $14,000 | 0.9% | 2 | Feb 26, 2019 |
| PFIZER, INC. | $14,000 | 0.9% | 3 | May 6, 2010 |
| SEMPRA ENERGY | $13,500 | 0.9% | 5 | Jan 10, 2024 |
| BIOMARIN PHARMACEUTICAL, INC. | $13,000 | 0.9% | 3 | Nov 13, 2025 |
| ALKERMES INC. | $12,000 | 0.8% | 4 | May 28, 2020 |
| AMYLIN PHARMACEUTICALS | $11,691 | 0.8% | 6 | Aug 30, 2010 |
| BIOGEN INC. | $11,000 | 0.7% | 2 | Aug 2, 2018 |
| METABASIS | $10,530 | 0.7% | 5 | Feb 28, 2006 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| BIOCOM PURCHASING GROUP | $259,900 | 17.1% | 3 | Aug 13, 2022 |
| GENENTECH | $73,750 | 4.9% | 16 | Sep 30, 2013 |
| GENENTECH | $55,000 | 3.6% | 9 | Aug 20, 2019 |
| NEUROCRINE BIOSCIENCES, INC. | $53,155 | 3.5% | 7 | Dec 18, 2025 |
| NOVARTIS | $34,300 | 2.3% | 8 | Aug 29, 2024 |
| ARENA PHARMACEUTICALS | $33,815 | 2.2% | 9 | Mar 23, 2011 |
| LIFE TECHNOLOGIES | $27,100 | 1.8% | 7 | Dec 23, 2014 |
| PFIZER INC. | $26,800 | 1.8% | 6 | Oct 23, 2018 |
| GILEAD SCIENCES, INC. | $24,900 | 1.6% | 3 | Mar 12, 2025 |
| BIOGEN IDEC PHARMACEUTICALS CORP | $23,495 | 1.5% | 6 | Jul 26, 2010 |
| INVITROGEN | $21,650 | 1.4% | 5 | May 28, 2008 |
| SUNOVION PHARMACEUTICALS INC. | $21,500 | 1.4% | 6 | Nov 1, 2022 |
| AMGEN INC. | $20,000 | 1.3% | 4 | Oct 3, 2024 |
| AMGEN INC. STATE POLITICAL CONTRIBUTIONS ACCOUNT REVOCABLE TRUST | $20,000 | 1.3% | 4 | Oct 5, 2023 |
| LIGAND PHARMACEUTICALS | $20,000 | 1.3% | 6 | Oct 12, 2006 |
| SEMPRA ENERGY | $18,000 | 1.2% | 6 | Jul 2, 2019 |
| GEN-PROBE, INC. | $14,650 | 1% | 5 | Jul 28, 2010 |
| NOVARTIS PHARMACEUTICALS CORP. | $14,000 | 0.9% | 2 | Feb 26, 2019 |
| PFIZER, INC. | $14,000 | 0.9% | 3 | May 6, 2010 |
| SEMPRA ENERGY | $13,500 | 0.9% | 5 | Jan 10, 2024 |
| BIOMARIN PHARMACEUTICAL, INC. | $13,000 | 0.9% | 3 | Nov 13, 2025 |
| ALKERMES INC. | $12,000 | 0.8% | 4 | May 28, 2020 |
| AMYLIN PHARMACEUTICALS | $11,691 | 0.8% | 6 | Aug 30, 2010 |
| BIOGEN INC. | $11,000 | 0.7% | 2 | Aug 2, 2018 |
| METABASIS | $10,530 | 0.7% | 5 | Feb 28, 2006 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.